Tenax Therapeutics (TENX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 01-2008 | 10-2007 | 07-2007 | 04-2007 | 01-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,285 | -1,959 | -1,027 | N/A | -2,298 |
| Depreciation Amortization | 25 | 33 | 18 | N/A | 118 |
| Accounts receivable | 113 | 56 | 28 | N/A | -17 |
| Other Working Capital | -248 | 447 | 343 | N/A | 252 |
| Other Operating Activity | 2,778 | 958 | 590 | 0 | 969 |
| Operating Cash Flow | $-1,616 | $-465 | $-49 | $N/A | $-976 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -16 | -8 | N/A | N/A | N/A |
| Purchase Sale Intangibles | N/A | N/A | -6 | N/A | N/A |
| Other Investing Activity | 0 | 0 | -6 | 0 | -16 |
| Investing Cash Flow | $-16 | $-8 | $-6 | $N/A | $-16 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 2,335 | 40 | 40 | N/A | N/A |
| Debt Issued | 266 | 418 | 125 | N/A | 1,014 |
| Other Financing Activity | -44 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $2,557 | $458 | $165 | $N/A | $1,014 |
| Beginning Cash Position | 16 | 16 | 16 | N/A | 0 |
| End Cash Position | 940 | 1 | 126 | N/A | 22 |
| Net Cash Flow | $924 | $-16 | $110 | $N/A | $22 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,616 | -465 | -49 | N/A | -976 |
| Capital Expenditure | -16 | -8 | N/A | N/A | N/A |
| Free Cash Flow | -1,633 | -473 | -49 | 0 | -976 |